Daily Archives: 23 May, 2023

May 2023 | Sale of Oncimmune Limited to Freenome

Sale of Oncimmune Limited to Freenome Oncimmune Holdings plc, the leading global immunodiagnostics group, today announces that it has sold its wholly-owned subsidiaries, Oncimmune Limited (including the CEmarked IVD EarlyCDT® Lung blood test, antibody platform and research and development pipeline) and Oncimmune Europe GmbH to Freenome Holdings, Inc. for a total of £13M in cash.…

May 2023 | IPF Partners Closes a Debt Financing with Patient21, as Part of its €100M Series C

IPF Partners Closes a Debt Financing with Patient21, as Part of its €100M Series C Patient21, a four-year-old German startup that combines a digital healthcare platform with real-world brick-and-mortar clinics, has raised €100 million ($108 million) in a Series C round of funding led by Israeli VC firm Pitango, constituting a mix of equity and…